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Cholesterol represents one of the key constituents of small, dynamic, sterol- and sphingolipid-enriched domains on the plasma 
membrane. It has been reported that many viruses depend on plasma membrane cholesterol for efficient infection. In this study, 
the role of the plasma membrane cholesterol in porcine reproductive and respiratory syndrome virus (PRRSV) infection of 
MARC-145 cells was investigated. Pretreatment of MARC-145 cells with methyl-β-cyclodextrin (MβCD), a drug used to de-
plete cholesterol from cellular membrane, significantly reduced PRRSV infection in a dose-dependent manner. This inhibition 
was partially reversed by supplementing exogenous cholesterol following MβCD treatment, suggesting that the inhibition of 
PRRSV infection was specifically mediated by removal of cellular cholesterol. Further detailed studies showed that depletion 
of cellular membrane cholesterol significantly inhibited virus entry, especially virus attachment and release. These results in-
dicate that the presence of cholesterol in the cellular membrane is a key component of PRRSV infection. 
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Porcine reproductive and respiratory syndrome (PRRS), 
characterized by severe reproductive failure in sows and 
respiratory distress in piglets and growing pigs, is now con-
sidered one of the most economically important diseases in 
countries with intensive swine industries [13]. PRRS virus 
(PRRSV), the etiology of PRRS, is a positive-strand RNA 
virus that belongs to the genus Arterivirus, family Arte-
riviridae, along with Lactate-dehydrogenase-elevating virus 
(LDV) of mice, Equine arteritis virus (EAV) and Simian 
hemorrhagic fever virus (SHFV) [4]. It has been demon-
strated that PRRSV has a strong tropism for cells of the 
monocyte/macrophage lineage in vivo, and for porcine al-
veolar macrophages (PAM) and African green monkey 
kidney cells (MARC-145) in vitro [58]. Accumulating 
evidence has revealed that the replication of PRRSV in cul-
tured cells partially depends on the composition of the host 
cellular plasma membrane [9,10]. Cellular surface mole-
cules, such as heparan sulfate and sialoadhesin, play an im-
portant role in PRRSV attachment and internalization 
[1113]. Moreover, simian vimentin and CD151 were con-
sidered to play a role in PRRSV infection of MARC-145 
cells [14,15]. However, some links within the detailed 
mechanism involved in PRRSV replication cycle remain 
poorly understood. 
The infectivity of enveloped viruses often depends on the 
lipid composition of the host cell membrane. For instance, 
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infection by Semliki Forest virus, a species of the Alpha-
virus genus, requires both cholesterol and sphingolipids 
[16,17]. Additionally, virus entry and assembly of certain 
retroviruses and filoviruses depend on cholesterol-rich 
membrane microdomains [18,19]. Cholesterol is an abun-
dant, key component of the eukaryotic cell membrane that 
forms liquid-ordered microenvironments in the plasma 
membrane due to its rigidity and hydrophobicity [20]. Pre-
vious studies demonstrated that plasma membrane choles-
terol plays an important role in the entry and infection pro-
cesses of many viruses, especially in some enveloped vi-
ruses [21], including Human immunodeficiency virus type 1 
(HIV-1) [22], Poliovirus [23], Murine coronavirus [24], 
Vaccinia virus [25], Herpes simplex virus [26], 
Foot-and-mouth disease virus [27], and Severe acute res-
piratory syndrome-related coronavirus (SARS-CoV) [28]. 
Moreover, the plasma membrane cholesterol content also 
affects the release of Influenza A virus from the infected cell 
[29]. However, few reports on the potential relationship 
between cholesterol and the replication of viruses in the 
Arteriviridae exist, although it was recently reported that 
cholesterol is a determinant of Equine arteritis virus entry 
[30].  
In this study, we investigated whether plasma membrane 
cholesterol plays a role during PRRSV infection and at 
which step(s) it functions. Our study clearly showed that 
depletion of cholesterol from host cells inhibited virus in-
fection, and primarily affected virus entry and release pro-
cesses. 
1  Materials and methods 
1.1  Viruses, cells and reagents 
PRRSV strain CH-1a, the first field isolate from China, was 
kindly provided by Dr. Tong G. Z. (Shanghai Veterinary 
Research Institute, Shanghai, China). PRRSV strain WUH3, 
a highly pathogenic North American-type PRRSV, was iso-
lated in 2007 [31]. MARC-145 cells were cultured and 
maintained in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) at 37°C 
in a humidified 5% CO2 incubator. Methyl-β-cyclodextrin 
(MβCD) and water-soluble cholesterol were purchased from 
Sigma (St Louis, USA). 
1.2  Virus purification and biotinylation 
To biotinylate PRRSV, the virus was first purified follow-
ing the protocols described by Nauwynck et al. [11]. The 
titer of the purified virus was approximately 5×106 TCID50 
mL1 (50% tissue culture infectious doses mL1), as deter-
mined by a cytopathic effect (CPE) assay in MARC-145 
cells. The protein concentration of the virus preparation was 
2 mg mL1, as determined by the Bradford assay with bo-
vine serum albumin (BSA) used as a protein quantitation 
standard. Biotinylation was performed with a protein bioti-
nylation kit (GE Healthcare, Uppsala, Sweden), according 
to manufacturer’s instructions. The biotinylated viruses 
were collected after purification on a Sephadex G-25 col-
umn and diluted in phosphate-buffered saline (PBS; pH 7.4) 
at a concentration of 0.2 mg mL1 and stored at 80°C. Vi-
rus infectivity and the ability to enter cells were not signifi-
cantly decreased after being biotinylated. 
1.3  MβCD treatment of cells 
1.3.1  MβCD toxicity assay 
To determine the toxicity of MβCD, confluent MARC-145 
cells in 96-well plates were treated with serum-free DMEM 
with or without MβCD. After incubation at 37°C for 1 h, 
MβCD-treated cells and mock-treated cells were harvested 
for the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo- 
lium bromide (MTT) assay to detect cell viability.  
1.3.2  Measurement of cellular cholesterol content 
To determine if treatment with MβCD reduces the cellular 
cholesterol content, MARC-145 cells in 24-well plates were 
washed three times with cold PBS, and then incubated for 1 h 
with serum-free DMEM (control cells) or various concen-
trations of MβCD (treated cells). After three additional 
washes with PBS, cells were harvested and the cholesterol 
content was measured using the Amplex Red Cholesterol 
Assay Kit (Molecular Probes, Oregon, USA), as directed by 
the manufacturer. 
1.3.3  Cholesterol depletion 
To deplete plasma membrane cholesterol, confluent 
MARC-145 cells in 24-well plates were washed three times 
with cold PBS, and then incubated for 1 h with serum-free 
DMEM (control cells) or DMEM containing 10 mmol L1 
MβCD (treated cells). 
1.3.4  Cholesterol replenishment 
To replenish plasma membrane cholesterol, the protocols 
established by Popik et al. [32] were used. In brief, conflu-
ent MARC-145 cells in 24-well plates were treated with 
serum-free DMEM (control cells) or DMEM containing 10 
mmol L1 MβCD (treated cells) for 1 h. Cells were then 
washed three times with PBS and incubated with serum-free 
DMEM alone or DMEM containing 400 μg mL1 wa-
ter-soluble cholesterol for 1 h. After three washes with PBS, 
cells were harvested for cholesterol level detection or in-
fected with PRRSV. 
1.4   RNA extraction and real-time RT-PCR 
Total RNA was extracted from cell suspensions or superna-
tant with RNAprep Micro Kit (Tiangen, Beijing, China), 
according to the manufacturer’s instructions. RNA was re- 
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versetranscribed into cDNA using ReverTra Ace-α (Toyobo, 
Osaka, Japan) with Oligo (dT)20. Quantitative real-time 
PCR was performed according to protocols described by 
Egli et al. [33]. In brief, the generated cDNA was amplified 
by quantitative real-time PCR using primers for the PRRSV 
ORF7 gene, reverse primer (5′-AAATGGGGCTTCTCCG- 
GGTTTT-3′) and forward primer (5′-TCAGCTGTGCCA- 
AATGCTGG-3′), and specific fluorescent probe (5′-TCC- 
CGGTCCCTTGCCTCTGGA-3′; sense orientation), which 
was 5′- labeled with 6-carboxyfluorescein (FAM; reporter) 
and tetramethylrhodamine (TAMRA) at its 3′-end. Re-
al-time PCR was performed in a single tube in an ABI 
Prism 7500 Real-Time PCR System (Applied Biosystems, 
Foster City, CA). For each run, four no-template controls 
containing water instead of DNA, as well as five PRRSV 
ORF7 gene standards corresponding to 1012, 1011, 1010, 109, 
108 copies per tube were included. Samples of interest were 
run in triplicate. Data from the TaqMan® run were analyzed 
using the SDS software (Version 1.7; Applied Biosystems). 
1.5  Virion penetration analysis using confocal micros-
copy 
Confluent MARC-145 cells in 24-well plates were incubat-
ed with 10 μg of biotinylated PRRSV in PBS per well at 
4°C for 1 h to achieve the maximal virus-cell attachment. 
Supernatants were removed and the cells were washed three 
times with cold PBS. Cells were next left untreated, or 
treated with MβCD, or treated with MβCD and cholesterol 
replenishment, as described above. During the treatment, 
viruses complete the penetration process. After removal of 
the supernatant, cells were incubated in DMEM containing 
2% FBS for 1 h, and then washed three times with cold 
PBSA and incubated with 1:50-diluted streptavidin-fluo- 
rescein isothiocyanate (FITC) for 1 h on ice. Subsequently, 
cells were washed once with PBS and resuspended in cold 
PBS containing 4% paraformaldehyde and fixed for 10 min 
at room temperature. After removal of paraformaldehyde, 
cells were washed twice with PBS containing 2% FBS, and 
the biotinylated virions were visualized on a confocal laser 
scanning microscope (LSM 510 Meta; Carl Zeiss, Gottingen, 
Germany). 
1.6  Statistical analysis 
Student’s t-test was used to evaluate differences in results 
and P<0.05 was considered statistically significant. 
2  Results 
2.1  MβCD treatment of MARC-145 reduces the cellu-
lar cholesterol content and has little effect on cell viabil-
ity 
To investigate the effect of MβCD on the cholesterol level 
of MARC-145 cells, MARC-145 cells were mock-treated or 
treated with various concentrations of MβCD. As shown in 
Figure 1A, MβCD treatment significantly reduced cellular 
cholesterol levels in a dose-dependent manner. When the 
concentration of MβCD was up to 10 mmol L1, cellular 
cholesterol level was reduced by approximately 75% com-
pared with that in mock-treated cells. As the concentration 
of MβCD was further increased (>10 mmol L1), cellular 
cholesterol level was no longer reduced, indicating that the 
remaining 25% cholesterol represented threshold levels of 
cholesterol which could not be extracted by higher doses of 
MβCD.  
After confirming the effect of MβCD on MARC-145 
cellular cholesterol, analyses were performed to exclude the 
possibility that MβCD causes cell toxicity. To this end, cell 
viabilities were detected after treatment with various con-
centration of MβCD by MTT. As shown in Figure 1B, 
MβCD had little cytotoxicity on MARC-145 cells when the 
concentration of MβCD was <10 mmol L1 (Figure 1B). 
Accordingly, 10 mmol L1 MβCD was used for all the sub-
sequent experiments. 
2.2  Cholesterol depletion inhibits PRRSV infection 
It is known that the plasma membrane lipid composition 
plays a key role in the infection by many enveloped viruses  
 
 
Figure 1  The effect of MβCD on cholesterol depletion and MARC-145 
cell viability. A, Reduction of cholesterol level in MARC-145 cells. B, 
Toxicity of MβCD to MARC-145 cells. Error bars indicate the standard  
deviations of three independent experiments. 
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[2428]. To investigate the role of plasma membrane cho- 
lesterol in the infection of PRRSV, MARC-145 cells were 
mock-treated or treated with various concentrations of 
MβCD and infected with PRRSV strain CH-1a at 104.5 
TCID50 per well. After incubation for 36 h, cell suspensions 
were harvested and virus production was determined by 
TCID50 assay on MARC-145 cells. As shown in Figure 2A, 
MβCD treatment inhibited the infection of PRRSV strain 
CH-1a in a dose-dependent manner, suggesting that choles-
terol is necessary for PRRSV replication in MARC-145 
cells. Moreover, treatment with 10 mmol L1 MβCD effi-
ciently reduced virus titer to 102.75 TCID50 mL
1 compared 
with that of 106.5 TCID50 mL
1 in mock-treated cells.  
To further elucidate the effects of MβCD on the replica-
tion cycle of PRRSV, mock-treated and MβCD-treated cells 
were infected with PRRSV strain CH-1a at 104.5 TCID50 per 
well. Cell suspensions were harvested at various times 
post-infection (p.i.) and the titers of virus production in this 
cell suspension were determined. As shown in Figure 2B, 
virus reproduction was significantly inhibited in MβCD- 
treated cells, and virus titers at all stages of the replication 
cycle were notably reduced compared with those in 
mock-treated cells. Specifically, at 36 h p.i., virus titers in 
MβCD-treated cells were 7.9×103-fold lower than that in 
mock-treated cells. We also investigated the role of plasma 
membrane cholesterol in the infection of PRRSV strain 
WUH3, a highly pathogenic PRRSV that has been emerging 
in China in recent years. Significant inhibitory effects were 
observed (Figure 2C), indicating that the inhibitory effects 
of plasma membrane cholesterol on PRRSV replication are 
not strain-specific.  
If the inhibition of PRRSV replication was specifically 
due to the cholesterol depletion by MβCD, then cholesterol 
replenishment in MβCD-treated cells should restore PRRSV 
replication. To clarify this hypothesis, MβCD-treated cells 
were incubated with DMEM containing water-soluble cho-  
 
 
Figure 2  Cholesterol depletion inhibits PRRSV infection. A, Virus titers determined by TCID50 (50% tissue culture infective dose) assay at 36 h p.i. after 
cholesterol depletion. B and C, Virus yields of PRRSV strains CH-1a (B) and WUH3 (C) from mock-treated (■) and MβCD-treated (10 mmol L1) (▲) cells 
at various times after infection. D, Cholesterol levels measured from equal number of mock-treated, MβCD-treated or MβCD-cholesterol-treated cells. E,  
Virus titer at 36 h p.i. after cholesterol depletion or cholesterol replenishment. Error bars indicate the standard deviations of three independent experiments. 
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lesterol and then cholesterol levels were measured. As 
shown in Figure 2D, the cellular cholesterol level of 
MβCD-cholesterol-treated cells was partially restored to 
85% of mock-treated cell cholesterol levels. Subsequently, 
virus yields from the infected MβCD-cholesterol-treated  
cells were assayed and compared with that from 
MβCD-treated cells. The titer of PRRSV from the infected 
MβCD-cholesterol-treated cells was increased to approxi-
mately 3.35×103-fold of that from MβCD-treated cells 
(Figure 2E). These results definitively demonstrated that 
decreasing cellular cholesterol levels resulted in the reduced 
ability of PRRSV replication and with the replenishment of 
cellular cholesterol, virus replication was restored to a cer-
tain extent.  
2.3  Cholesterol depletion inhibits PRRSV entry 
To further illuminate at which step(s) cholesterol depletion 
reduces PRRSV replication, we first investigated the effect 
of cholesterol depletion on virus entry. Mock-treated, 
MβCD-treated and MβCD-cholesterol-treated MARC-145 
cells in 24-well plates were infected with PRRSV at 104.5 
TCID50 per well. After incubation for 1 h, cells were har-
vested and intracellular PRRSV RNA levels were measured 
by real-time RT-PCR. As shown in Figure 3A, compared 
with the number of viral genomes in mock-treated cells, a 
significant decrease (80%) in viral genomes in MβCD- 
treated cells was detected. Furthermore, cholesterol replen-
ishment partially restored intracellular viral genomes and 
there was only a 17% reduction after adding exogenous 
cholesterol. These results suggest that entry of PRRSV is 
dependent on the cellular membrane cholesterol. 
The entry phases of PRRSV infection can be divided into 
two stages: the first stage requires PRRSV attachment to 
cells, and the second stage occurs when PRRSV penetrates 
the cellular membrane. To determine whether MβCD re-
duces PRRSV attachment to MARC-145 cells, mock-  
treated, MβCD-treated or MβCD-cholesterol-treated MARC- 
145 cells were infected with PRRSV at 4°C for 1 h. All 
cells were collected and virus genomes were detected by 
quantitative real-time PCR assay. As shown in Figure 3B, 
virus genomes presented in MβCD-treated cells were only 
23.8% of that presented in mock-treated cells. Furthermore, 
cholesterol replenishment partially restored virus attach-
ment to approximately 75% of which presented in mock- 
treated cells, suggesting that the effect was specifically due 
to the cholesterol depletion (Figure 3B). 
The effect of cholesterol depletion on virus attachment 
was defined, but next we determined whether penetration of 
PRRSV into MARC-145 cell was also affected by choles-
terol depletion. To this end, MARC-145 cells in 24-well 
plates were infected with 10 μg biotinylated-PRRSV per 
well and were mock-treated or treated with MβCD or  
 
Figure 3  Cholesterol depletion inhibits PRRSV entry. A, Quantitative 
RT-PCR analysis of PRRSV entry. B, Quantitative RT-PCR analysis of 
PRRSV attachment. Error bars indicate the standard deviations of three  
independent experiments. 
MβCD-cholesterol. During the treatment, virions attached 
on these cells completed the penetration process and were 
detected by confocal microscopy. No significant differences 
were observed between various groups (data not shown), 
suggesting that MβCD treatment has little effect on the se- 
cond stage of virus entry. Altogether, these data indicated 
that cellular membrane cholesterol was required for PRRSV 
entry into MARC-145 cells, and its depletion by MβCD 
mainly affects virus attachment, rather than penetration.  
2.4  Cholesterol depletion results in an enhanced re-
lease of virus particles with reduced infectivity 
To investigate the effect of MβCD on virus release from 
MARC-145 cells, cells were infected with PRRSV strain 
CH-1a at 104.5 TCID50 per well. At 24 h p.i., cells were left 
untreated or treated with MβCD or MβCD-cholesterol. At 
the indicated time points post-treatment, the supernatants 
were harvested and the virus was detected by real-time 
RT-PCR. The data indicated that the number of viral ge-
nomes present in MβCD-treated cells was notably higher 
than those in mock-treated cells at each time point, and this 
increase was partially neutralized by cholesterol replenish-
ment (Figure 4A). This suggests that the ability of virus 
release from MARC-145 is inversely related to cellular 
cholesterol level. 
To further determine the effect of cholesterol depletion   
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Figure 4  Cholesterol depletion results in an enhanced release of virus 
particles with reduced infectivity. A, Quantitative RT-PCR measurement of 
PRRSV genomes released in cholesterol depleted or cholesterol replen-
ished cell culture supernatant at various times after the treatment. B, Virus 
infectivity of virions released from mock-treated, MβCD-treated and 
MβCD-cholesterol-treated cells. Error bars indicate the standard deviations  
of three independent experiments. 
on virus release, the infectivity of released virus was exam-
ined. MARC-145 cells were infected with harvested super-
natant at the same amount according to the results of re-
al-time RT-PCR. At 36 h p.i., the replication of PRRSV in 
MARC-145 cells was analyzed by detecting viral genomes 
in infected cell suspensions by real-time RT-PCR. As 
shown in Figure 4B, the amount of PRRSV genomes ex-
pressed in cells infected with released virus from 
MβCD-treated cells was approximately 10.6% of that in 
cells infected with released virus from mock-treated cells, 
and cholesterol replenishment partially counteracted this 
effect. These findings indicate that the infectivity of virus 
released from MβCD-treated cells was decreased compared 
with those released from MβCD-cholesterol- treated and 
mock-treated cells. According to these data, we can con-
clude that MβCD treatment caused an enhancement of virus 
particle released from infected cells but the infectivity of 
released viruses was decreased by this treatment.  
3  Discussion 
Many studies have reported that cholesterol is involved in 
the replication of some enveloped virus, such as Herpes 
simplex virus [26], Vaccinia virus [25], Murine coronavirus 
[24], SARS-CoV [28], Varicella-zoster virus [34], and 
Pseudorabies virus [35]. The present study showed that the 
inhibition of PRRSV infection in vitro occurred as host cell 
membrane cholesterol decreased due to MβCD treatment. 
This effect could be counteracted by the addition of exoge-
nous cholesterol and demonstrated the importance of mem-
brane cholesterol for PRRSV infection.  
Being an essential component of cell membrane, choles-
terol could potentially inhibit virus entry by several differ-
ent mechanisms. First, cholesterol may affect virus entry by 
modifying the interaction of the virus particle with host cell 
membrane. Cholesterol level is important for maintaining 
biological membrane fluidity [36], and its removal could 
reduce lateral diffusion within the membrane. This reduc-
tion in fluidity could probably influence entry of PRRSV 
within the membrane. Second, the lipid environment, in-
cluding cholesterol level, is known to affect the charge 
properties of some ion channels [37], and the ion channels 
formed on cellular membrane require the presence of cho-
lesterol for effective cytoplasmic delivery of the viral ge-
nome during virus entry. Cholesterol and sphingolipids are 
components of lipid rafts, and lipid recognition by certain 
proteins of viruses might be imperative for virus entry [38]. 
Moreover, there are also other studies indicating that cho-
lesterol removal resulted in an inhibition of cellular signal-
ing pathways [39]. 
A previous study demonstrated that the entry of Equine 
arteritis virus, another member of Arteriviridae, could also 
be inhibited by cholesterol depletion, and virus entry re-
quires plasma membrane cholesterol [30]. In the current 
study, we examined the effect of plasma membrane choles-
terol on PRRSV attachment and penetration, the two stages 
of virus entry. We found that cholesterol mainly affects vi-
rus attachment, rather than penetration. It was reported that 
PRRSV enters porcine alveolar macrophages (PAMs) via 
receptor-mediated endocytic vesicles and the low 
pH-dependent endocytic pathway [11]. Thus, it is possible 
that the effect of plasma membrane cholesterol on PRRSV 
entry into MARC-145 cell is also due to its influence on the 
endocytosis process. 
A significant finding of the present study is that choles-
terol depletion facilitated the release process of PRRSV but 
also resulted in decreased infectivity of released virus parti-
cles. This finding is consistent with reports showing that 
cholesterol depletion caused an enhancement of Influenza A 
virus particle release from infected cells and a decreased 
infectivity of virus particles [29]. In addition, the infectivity 
of Newcastle disease virus could be reduced by cholesterol 
depletion and possibly due to virus particles released from 
cholesterol-depleted cells having heterogeneous densities 
and structural abnormalities [40]. Teissier and Pecheur [38] 
had demonstrated that the molecular shape of lipids, in-
cluding cholesterol and sphingolipid, could affect mem-
brane curvature and further influence membrane defor-
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mation and fluidity. Thus, structural abnormalities of virus 
particles due to cholesterol depletion and the physical func-
tion of cholesterol in the plasma membrane may be respon-
sible for the findings reported herein.  
In conclusion, the current study demonstrated that both 
efficient entry of PRRSV into MARC-145 cells and the 
release of PRRSV are dependent on the presence of plasma 
membrane cholesterol. These data suggest that further in-
vestigation of the prevention and control of PRRSV, in par-
ticular, prevention of viral entry, is warranted. 
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